Delivery Order SPE2DB24D1205-SPE2DB25FCYFS
- Not listed
- This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,596.79, is for the delivery of Citalopram HBR 40 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,379.49 contract is for the delivery of 4,560,633,895 units of Citalopram HBR 40 mg tablets. The contract has an ultimate completion date of April 19, 2023. This contract award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,958.23, is a delivery order for 4,562,704,033 units of Citalopram HBR 40 mg tablets. The contract has a firm fixed price and an ultimate completion date of November 6, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,335.40, is for the delivery of 500 units of the prescription drug Citalopram HBR 40 mg tablets. This is a firm fixed-price delivery order contract, with a completion date of July 25, 2024. The contract was awarded on July 24, 2022 and does not have a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Citalopram Hydrobromide 40 mg tablets in 500-count bottles. The contract has a ceiling value of $39,805.17 and is a Firm Fixed Price Delivery Order, with a completion date of May 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of Citalopram HBR 40 mg tablets. The $5,663.20 firm-fixed-price delivery order has a performance period ending on May 7, 2025. This contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,312.23, is for the delivery of 500 bottles of Citalopram HBR 40 mg Tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,575.14, is for the delivery of Citalopram HBR 40 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYFSDelivery Order
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,292.87, is for the delivery of 500 units of Citalopram HBR 40 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 3, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables Amerisourcebergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 7/2/25 |